Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -66.3% | -7.2% | 1 / 3 | -5.9% | +1.51 pp | -1.87 pp | +5.5% | 0.00 | 12.34 | 252 | −5,9% | 2,6 | −66,3% | 12.34 | 7.37 | +67,4% |
| Pts | 0 | 0 | 4 | 0 | 8 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 13.700 (close price on 2026-10-19)EPS (TTM): 1.110
Financial charts
1.Revenue & growth
VND bn252Q2/26
1.Revenue & growth
VND bn252Q2/26
2.Profit & growth
VND bn2,63Q2/26
3.Profit mix (Penman)
VND bn6,98Q2/26
4.Margins & cost structure
%18.3%Q2/26
5.Returns & cash cycle
% · days10.8%Q2/26
6.Earnings quality & cash
VND bn17,2Q2/26
7.Asset structure
VND bn330Q2/26
8.Funding & debt health
VND bn · times330Q2/26
9.Revenue backlog
VND bn2,24Q2/26
10.Valuation
times · %12,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %526Q2/26
Adjusted EPS growth, latest quarter
-66.3%
Average adjusted EPS growth, 3 quarters
-47.4%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26